Viewing data from:

ENALAPRIL MALEATE

ANDA

ENALAPRIL MALEATE | A075178 | AIPING PHARMACEUTICAL INC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VASOTEC(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.0977

per ea

Lowest NADAC/Unit

$0.0647

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
50228023101ENALAPRIL MALEATE 20 MG TAB	$0.0977	EA	Generic	—	2026-06-17
50228023110ENALAPRIL MALEATE 20 MG TAB	$0.0977	EA	Generic	—	2026-06-17
50228022901ENALAPRIL MALEATE 5 MG TABLET	$0.0790	EA	Generic	—	2026-06-17
50228022910ENALAPRIL MALEATE 5 MG TABLET	$0.0790	EA	Generic	—	2026-06-17
50228023001ENALAPRIL MALEATE 10 MG TAB	$0.0679	EA	Generic	—	2026-06-17
50228023010ENALAPRIL MALEATE 10 MG TAB	$0.0679	EA	Generic	—	2026-06-17
50228022801ENALAPRIL MALEATE 2.5 MG TAB	$0.0647	EA	Generic	—	2026-06-17
50228022810ENALAPRIL MALEATE 2.5 MG TAB	$0.0647	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs13 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

FARMHISPANIA SAENALAPRIL MALEATE

DMF 115251995

DR REDDYS LABORATORIES LTDENALAPRIL MALEATE, USP

DMF 138361998

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDENALAPRIL MALEATE USP

DMF 143551999

NEULAND LABORATORIES LTDENALAPRIL MALEATE

DMF 154342001

NEULAND LABORATORIES LTDENALAPRIL MALEATE USP

DMF 199842006

SRI KRISHNA PHARMACEUTICALS LTDENALAPRIL MALEATE USP PROCESS-II

DMF 402112024

NEULAND LABORATORIES LTDENALAPRIL MALEATE USP (PROCESS-II)

DMF 436182026

MERCK RESEARCH LABORATORIES DIV MERCK CO INCInactiveENALAPRIL MALEATE & DILTIAZEM ER TABLETS

DMF 111701994

MAPRIMED SAInactiveENALAPRIL MALEATE

DMF 116561995

ESTEVE QUIMICA SAInactiveENALAPRIL MALEATE

DMF 118661996

WOCKHARDT LTDInactiveENALAPRIL MALEATE

DMF 127801997

KRKA DD NOVO MESTOInactiveENALAPRIL MALEATE

DMF 128091997

GEDEON RICHTER LTDInactiveENALAPRIL MALEATE

DMF 129391998

MEDICHEM SAInactiveENALAPRIL MALEATE

DMF 130551998

LEK PHARMACEUTICALS DDInactiveENALAPRIL MALEATE, ACTIVE SUBSTANCE

DMF 131141998

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveENALAPRIL MALEATE USP

DMF 138201998

CHEMSOURCE CORPInactiveENALAPRIL MALEATE DRUG SUBSTANCE

DMF 149382000

PHARMACEUTICAL WORKS POLPHARMA SAInactiveENALAPRIL MALEATE

DMF 189502005

APOTEX PHARMACHEM INDIA PVT LTDInactiveENALAPRIL MALEATE USP

DMF 190582005

MAPRIMED SAInactiveENALAPRIL MALEATE

DMF 203172007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Jun 3, 2004	ORIG -1	View Letter (PDF)
Mar 23, 2001	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 23, 2001

No patent or exclusivity listings for this strength.

#002 — 2.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 23, 2001

#003 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 23, 2001

#004 — 20MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 23, 2001